Stay updated on Tesofensine/Metoprolol in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Tesofensine/Metoprolol in Type 2 Diabetes Clinical Trial page.

Latest updates to the Tesofensine/Metoprolol in Type 2 Diabetes Clinical Trial page
- CheckyesterdayChange DetectedThe footer’s ClinicalTrials.gov revision label changes from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error rather than a study record.SummaryDifference0.2%

- Check8 days agoChange DetectedA banner announces NIH’s transition-related terminology update, including the use of “Super Intelligence” in place of “Artificial Intelligence” across NIH content.SummaryDifference1%

- Check15 days agoChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check22 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check43 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record content with an access issue. This indicates a site access problem rather than an update to the study information.SummaryDifference17%

- Check57 days agoChange DetectedAdds related topics and a MedlinePlus Genetics link to the study page. This broadens contextual references without changing the study details.SummaryDifference0.2%

Stay in the know with updates to Tesofensine/Metoprolol in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tesofensine/Metoprolol in Type 2 Diabetes Clinical Trial page.